TRON enters into a research collaboration with Astellas Pharma Inc., Japan

Mainz – TRON (Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz), a non-profit organization and internationally recognized leader in tumor immunology and cancer therapy research, has entered into a research collaboration with Astellas Pharma Inc., a company dedicated to improving the health of people through the provision of innovative and reliable pharmaceutical products.

“We are excited to collaborate with Astellas Pharma Inc. which highlights the quality of our research in oncology,” said Michael Foehlings, Managing Director of TRON. “Collaborations with key players in the pharmaceutical industry provide an excellent platform for the dissemination of research performed at TRON to address an unmet medical need and to improve patients’ lives.”